Abbisko Cayman Limited (2256.HK)

HKD 4.46

(-3.67%)

Operating Expenses Summary of Abbisko Cayman Limited

  • Abbisko Cayman Limited's latest annual operating expenses in 2023 was 19.06 Million CNY , up 4.59% from previous year.
  • Abbisko Cayman Limited's latest quarterly operating expenses in 2024 Q2 was 127.68 Million CNY , down 0.0% from previous quarter.
  • Abbisko Cayman Limited reported a annual operating expenses of 486.64 Million CNY in annual operating expenses 2022, up 44.48% from previous year.
  • Abbisko Cayman Limited reported a annual operating expenses of 336.82 Million CNY in annual operating expenses 2021, up 129.87% from previous year.
  • Abbisko Cayman Limited reported a quarterly operating expenses of 127.68 Million CNY for 2024 Q1, down -8.72% from previous quarter.
  • Abbisko Cayman Limited reported a quarterly operating expenses of 139.87 Million CNY for 2023 Q4, up 7.41% from previous quarter.

Annual Operating Expenses Chart of Abbisko Cayman Limited (2023 - 2019)

Historical Annual Operating Expenses of Abbisko Cayman Limited (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 19.06 Million CNY 4.59%
2022 486.64 Million CNY 44.48%
2021 336.82 Million CNY 129.87%
2020 146.53 Million CNY 47.25%
2019 99.51 Million CNY 0.0%

Peer Operating Expenses Comparison of Abbisko Cayman Limited

Name Operating Expenses Operating Expenses Difference
Uni-Bio Science Group Limited 325.05 Million HKD 94.136%
CK Life Sciences Int'l., (Holdings) Inc. 739.25 Million HKD 97.422%